Skip to Main Content

Pathogenic Wnt-beta catenin target genes in macrophages and fibrosis

Conditions

Immune System

What is the purpose of this trial?

The purpose of this research study is to better understand the development of systemic sclerosis (SSc)/scleroderma-related lung fibrosis (scarring)/interstitial lung disease (ILD) and how the development of scleroderma lung disease might be associated with scleroderma skin and esophageal disease. Study procedures will include: screening form, blood collection, skin biopsy collection, suture removal, and bronchoscopy.

  • Trial with
    National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMSD)
  • Start Date
    05/31/2019
  • End Date
    12/30/2023
Trial Image

For more information about this study, contact:

Shannon Teaw

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    08/05/2019
  • Study HIC
    #2000024862